1 year return (CAGR)
141.43%
Immunovant Inc Exchange (NASDAQ, USD)
IMVT
37.18
+0.23 (+0.62%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
19.10%
5 year return (CAGR)
33.74%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
7.68B
Price/Sales
1082.40
Ent value
7.00B
Price/Book
10.44
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
17.75%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 37.23 |
| Daily high | 37.49 |
| Daily low | 36.55 |
| Daily Volume | 1.03M |
| All-time high | 52.71 |
| 1y analyst estimate | 48.88 |
| Beta | 0.81 |
| EPS (TTM) | -2.62 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Feb 2026 |
Downside potential
Loading...
Downside potential data
| IMVT | S&P500 | |
| Current price drop from All-time high | -29.46% | -0.56% |
| Highest price drop | -93.59% | -56.47% |
| Date of highest drop | 16 Jun 2022 | 9 Mar 2009 |
| Avg drop from high | -50.24% | -10.68% |
| Avg time to new high | 24 days | 12 days |
| Max time to new high | 1466 days | 1805 days |
News
